Skip to content

Screener

Eligibility screening

Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis

Sponsored by Spyre Therapeutics, Inc.Study detailsClinicalTrials.gov

21 US sites in CA, CO, FL, KS +9

Before we begin

Who are you filling this out for?

Your answer affects how the questions are phrased.